Selected research
Market Analysis & Forecast
Global Biomedical Cold Chain Services Market Analysis and Forecast 2026-2032
Market perspective
The global Biomedical Cold Chain Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Biomedical Cold Chain Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Biomedical Cold Chain Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Biomedical Cold Chain Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Biomedical Cold Chain Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Biomedical Cold Chain Services include Csafe, DS Smith, Skycell, Sofrigam, Cold Chain Technologies, Nichirei Logistics Group, Sonoco, Alloga and Hemisphere Freight Services, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Biomedical Cold Chain Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Biomedical Cold Chain Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Biomedical Cold Chain Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biomedical Cold Chain Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biomedical Cold Chain Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biomedical Cold Chain Services revenue, projected growth trends, production technology, application and end-user industry.
Biomedical Cold Chain Services Segment by Company
Csafe
DS Smith
Skycell
Sofrigam
Cold Chain Technologies
Nichirei Logistics Group
Sonoco
Alloga
Hemisphere Freight Services
TEK Freight
Jump Up Logistics
Courier Express
Biocair
Tower Cold Chain
Patheon
Movianto
Pharmaceutical Technology
Biomedical Cold Chain Services Segment by Type
Shipping
Air Transport
Land Transportation
Others
Biomedical Cold Chain Services Segment by Application
Pharmaceuticals
Blood Supplies
Others
Biomedical Cold Chain Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical Cold Chain Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomedical Cold Chain Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical Cold Chain Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Biomedical Cold Chain Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Biomedical Cold Chain Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomedical Cold Chain Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Shipping
- Air Transport
- Land Transportation
- Others
Applications
- Pharmaceuticals
- Blood Supplies
- Others
Companies covered
- Csafe
- DS Smith
- Skycell
- Sofrigam
- Cold Chain Technologies
- Nichirei Logistics Group
- Sonoco
- Alloga
- Hemisphere Freight Services
- TEK Freight
- Jump Up Logistics
- Courier Express
- Biocair
- Tower Cold Chain
- Patheon
- Movianto
- Pharmaceutical Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Biomedical Cold Chain Services Market by Type
- 1.2.1 Global Biomedical Cold Chain Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Shipping
- 1.2.3 Air Transport
- 1.2.4 Land Transportation
- 1.2.5 Others
- 1.3 Biomedical Cold Chain Services Market by Application
- 1.3.1 Global Biomedical Cold Chain Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceuticals
- 1.3.3 Blood Supplies
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Biomedical Cold Chain Services Market Dynamics
- 2.1 Biomedical Cold Chain Services Industry Trends
- 2.2 Biomedical Cold Chain Services Industry Drivers
- 2.3 Biomedical Cold Chain Services Industry Opportunities and Challenges
- 2.4 Biomedical Cold Chain Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Biomedical Cold Chain Services Market Perspective (2021-2032)
- 3.2 Global Biomedical Cold Chain Services Growth Trends by Region
- 3.2.1 Global Biomedical Cold Chain Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Biomedical Cold Chain Services Market Size by Region (2021-2026)
- 3.2.3 Global Biomedical Cold Chain Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Biomedical Cold Chain Services Revenue by Players
- 4.1.1 Global Biomedical Cold Chain Services Revenue by Players (2021-2026)
- 4.1.2 Global Biomedical Cold Chain Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Biomedical Cold Chain Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Biomedical Cold Chain Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Biomedical Cold Chain Services Key Players Headquarters & Area Served
- 4.4 Global Biomedical Cold Chain Services Players, Product Type & Application
- 4.5 Global Biomedical Cold Chain Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Biomedical Cold Chain Services Market CR5 and HHI
- 4.6.3 2025 Biomedical Cold Chain Services Tier 1, Tier 2, and Tier 3
5 Biomedical Cold Chain Services Market Size by Type
- 5.1 Global Biomedical Cold Chain Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Biomedical Cold Chain Services Revenue by Type (2021-2032)
- 5.3 Global Biomedical Cold Chain Services Revenue Market Share by Type (2021-2032)
6 Biomedical Cold Chain Services Market Size by Application
- 6.1 Global Biomedical Cold Chain Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Biomedical Cold Chain Services Revenue by Application (2021-2032)
- 6.3 Global Biomedical Cold Chain Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Csafe
- 7.1.1 Csafe Company Information
- 7.1.2 Csafe Business Overview
- 7.1.3 Csafe Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Csafe Biomedical Cold Chain Services Product Portfolio
- 7.1.5 Csafe Recent Developments
- 7.2 DS Smith
- 7.2.1 DS Smith Company Information
- 7.2.2 DS Smith Business Overview
- 7.2.3 DS Smith Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.2.4 DS Smith Biomedical Cold Chain Services Product Portfolio
- 7.2.5 DS Smith Recent Developments
- 7.3 Skycell
- 7.3.1 Skycell Company Information
- 7.3.2 Skycell Business Overview
- 7.3.3 Skycell Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.3.4 Skycell Biomedical Cold Chain Services Product Portfolio
- 7.3.5 Skycell Recent Developments
- 7.4 Sofrigam
- 7.4.1 Sofrigam Company Information
- 7.4.2 Sofrigam Business Overview
- 7.4.3 Sofrigam Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.4.4 Sofrigam Biomedical Cold Chain Services Product Portfolio
- 7.4.5 Sofrigam Recent Developments
- 7.5 Cold Chain Technologies
- 7.5.1 Cold Chain Technologies Company Information
- 7.5.2 Cold Chain Technologies Business Overview
- 7.5.3 Cold Chain Technologies Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.5.4 Cold Chain Technologies Biomedical Cold Chain Services Product Portfolio
- 7.5.5 Cold Chain Technologies Recent Developments
- 7.6 Nichirei Logistics Group
- 7.6.1 Nichirei Logistics Group Company Information
- 7.6.2 Nichirei Logistics Group Business Overview
- 7.6.3 Nichirei Logistics Group Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.6.4 Nichirei Logistics Group Biomedical Cold Chain Services Product Portfolio
- 7.6.5 Nichirei Logistics Group Recent Developments
- 7.7 Sonoco
- 7.7.1 Sonoco Company Information
- 7.7.2 Sonoco Business Overview
- 7.7.3 Sonoco Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.7.4 Sonoco Biomedical Cold Chain Services Product Portfolio
- 7.7.5 Sonoco Recent Developments
- 7.8 Alloga
- 7.8.1 Alloga Company Information
- 7.8.2 Alloga Business Overview
- 7.8.3 Alloga Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.8.4 Alloga Biomedical Cold Chain Services Product Portfolio
- 7.8.5 Alloga Recent Developments
- 7.9 Hemisphere Freight Services
- 7.9.1 Hemisphere Freight Services Company Information
- 7.9.2 Hemisphere Freight Services Business Overview
- 7.9.3 Hemisphere Freight Services Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Hemisphere Freight Services Biomedical Cold Chain Services Product Portfolio
- 7.9.5 Hemisphere Freight Services Recent Developments
- 7.10 TEK Freight
- 7.10.1 TEK Freight Company Information
- 7.10.2 TEK Freight Business Overview
- 7.10.3 TEK Freight Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.10.4 TEK Freight Biomedical Cold Chain Services Product Portfolio
- 7.10.5 TEK Freight Recent Developments
- 7.11 Jump Up Logistics
- 7.11.1 Jump Up Logistics Company Information
- 7.11.2 Jump Up Logistics Business Overview
- 7.11.3 Jump Up Logistics Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.11.4 Jump Up Logistics Biomedical Cold Chain Services Product Portfolio
- 7.11.5 Jump Up Logistics Recent Developments
- 7.12 Courier Express
- 7.12.1 Courier Express Company Information
- 7.12.2 Courier Express Business Overview
- 7.12.3 Courier Express Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.12.4 Courier Express Biomedical Cold Chain Services Product Portfolio
- 7.12.5 Courier Express Recent Developments
- 7.13 Biocair
- 7.13.1 Biocair Company Information
- 7.13.2 Biocair Business Overview
- 7.13.3 Biocair Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.13.4 Biocair Biomedical Cold Chain Services Product Portfolio
- 7.13.5 Biocair Recent Developments
- 7.14 Tower Cold Chain
- 7.14.1 Tower Cold Chain Company Information
- 7.14.2 Tower Cold Chain Business Overview
- 7.14.3 Tower Cold Chain Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.14.4 Tower Cold Chain Biomedical Cold Chain Services Product Portfolio
- 7.14.5 Tower Cold Chain Recent Developments
- 7.15 Patheon
- 7.15.1 Patheon Company Information
- 7.15.2 Patheon Business Overview
- 7.15.3 Patheon Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.15.4 Patheon Biomedical Cold Chain Services Product Portfolio
- 7.15.5 Patheon Recent Developments
- 7.16 Movianto
- 7.16.1 Movianto Company Information
- 7.16.2 Movianto Business Overview
- 7.16.3 Movianto Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.16.4 Movianto Biomedical Cold Chain Services Product Portfolio
- 7.16.5 Movianto Recent Developments
- 7.17 Pharmaceutical Technology
- 7.17.1 Pharmaceutical Technology Company Information
- 7.17.2 Pharmaceutical Technology Business Overview
- 7.17.3 Pharmaceutical Technology Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 7.17.4 Pharmaceutical Technology Biomedical Cold Chain Services Product Portfolio
- 7.17.5 Pharmaceutical Technology Recent Developments
8 North America
- 8.1 North America Biomedical Cold Chain Services Revenue (2021-2032)
- 8.2 North America Biomedical Cold Chain Services Revenue by Type (2021-2032)
- 8.2.1 North America Biomedical Cold Chain Services Revenue by Type (2021-2026)
- 8.2.2 North America Biomedical Cold Chain Services Revenue by Type (2027-2032)
- 8.3 North America Biomedical Cold Chain Services Revenue Share by Type (2021-2032)
- 8.4 North America Biomedical Cold Chain Services Revenue by Application (2021-2032)
- 8.4.1 North America Biomedical Cold Chain Services Revenue by Application (2021-2026)
- 8.4.2 North America Biomedical Cold Chain Services Revenue by Application (2027-2032)
- 8.5 North America Biomedical Cold Chain Services Revenue Share by Application (2021-2032)
- 8.6 North America Biomedical Cold Chain Services Revenue by Country
- 8.6.1 North America Biomedical Cold Chain Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Biomedical Cold Chain Services Revenue by Country (2021-2026)
- 8.6.3 North America Biomedical Cold Chain Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Biomedical Cold Chain Services Revenue (2021-2032)
- 9.2 Europe Biomedical Cold Chain Services Revenue by Type (2021-2032)
- 9.2.1 Europe Biomedical Cold Chain Services Revenue by Type (2021-2026)
- 9.2.2 Europe Biomedical Cold Chain Services Revenue by Type (2027-2032)
- 9.3 Europe Biomedical Cold Chain Services Revenue Share by Type (2021-2032)
- 9.4 Europe Biomedical Cold Chain Services Revenue by Application (2021-2032)
- 9.4.1 Europe Biomedical Cold Chain Services Revenue by Application (2021-2026)
- 9.4.2 Europe Biomedical Cold Chain Services Revenue by Application (2027-2032)
- 9.5 Europe Biomedical Cold Chain Services Revenue Share by Application (2021-2032)
- 9.6 Europe Biomedical Cold Chain Services Revenue by Country
- 9.6.1 Europe Biomedical Cold Chain Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Biomedical Cold Chain Services Revenue by Country (2021-2026)
- 9.6.3 Europe Biomedical Cold Chain Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Biomedical Cold Chain Services Revenue (2021-2032)
- 10.2 China Biomedical Cold Chain Services Revenue by Type (2021-2032)
- 10.2.1 China Biomedical Cold Chain Services Revenue by Type (2021-2026)
- 10.2.2 China Biomedical Cold Chain Services Revenue by Type (2027-2032)
- 10.3 China Biomedical Cold Chain Services Revenue Share by Type (2021-2032)
- 10.4 China Biomedical Cold Chain Services Revenue by Application (2021-2032)
- 10.4.1 China Biomedical Cold Chain Services Revenue by Application (2021-2026)
- 10.4.2 China Biomedical Cold Chain Services Revenue by Application (2027-2032)
- 10.5 China Biomedical Cold Chain Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Biomedical Cold Chain Services Revenue (2021-2032)
- 11.2 Asia Biomedical Cold Chain Services Revenue by Type (2021-2032)
- 11.2.1 Asia Biomedical Cold Chain Services Revenue by Type (2021-2026)
- 11.2.2 Asia Biomedical Cold Chain Services Revenue by Type (2027-2032)
- 11.3 Asia Biomedical Cold Chain Services Revenue Share by Type (2021-2032)
- 11.4 Asia Biomedical Cold Chain Services Revenue by Application (2021-2032)
- 11.4.1 Asia Biomedical Cold Chain Services Revenue by Application (2021-2026)
- 11.4.2 Asia Biomedical Cold Chain Services Revenue by Application (2027-2032)
- 11.5 Asia Biomedical Cold Chain Services Revenue Share by Application (2021-2032)
- 11.6 Asia Biomedical Cold Chain Services Revenue by Country
- 11.6.1 Asia Biomedical Cold Chain Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Biomedical Cold Chain Services Revenue by Country (2021-2026)
- 11.6.3 Asia Biomedical Cold Chain Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Biomedical Cold Chain Services Revenue (2021-2032)
- 12.2 SAMEA Biomedical Cold Chain Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Biomedical Cold Chain Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Biomedical Cold Chain Services Revenue by Type (2027-2032)
- 12.3 SAMEA Biomedical Cold Chain Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Biomedical Cold Chain Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Biomedical Cold Chain Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Biomedical Cold Chain Services Revenue by Application (2027-2032)
- 12.5 SAMEA Biomedical Cold Chain Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Biomedical Cold Chain Services Revenue by Country
- 12.6.1 SAMEA Biomedical Cold Chain Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Biomedical Cold Chain Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Biomedical Cold Chain Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst